The present invention provides novel lipoglycopeptide compounds which are Type 1 signal peptidase inhibitors (SpsB). Compounds of the present invention are useful for the treatment of various bacterial related infectious diseases, particularly when used as a potentiator of a β-lactam antibiotic such as imipenem and ertapenem. Accordingly, the present invention provides a method for the treatment of bacterial related infections using the compounds described herein, either alone or in combination with a β-lactam antibiotic.
本发明提供了一种新型的脂肽
多糖肽类化合物,它们是一类信号肽酶
抑制剂(SpsB)。本发明的化合物可用于治疗各种细菌相关感染疾病,特别是在与β-内酰胺类抗生素(如
亚胺培南和
依达拉奉)一起使用时作为增效剂。因此,本发明提供了一种使用本文所述化合物单独或与β-内酰胺类抗生素联合治疗细菌相关感染的方法。